Quantcast

Latest Cancer immunotherapy Stories

2015-03-10 08:35:00

Investment bolsters immediate capital needs for progressing clinical programs SEATTLE, March 10, 2015 /PRNewswire/ -- TapImmune,

oxygenation
2015-03-05 13:25:05

Researchers at Northwestern University have announced a cancer-treatment breakthrough based on three decades of work.

2015-03-02 08:34:06

SOUTH SAN FRANCISCO, Calif., March 2, 2015 /PRNewswire/ -- CytomX, a biotechnology company developing Probody(TM) therapeutics for the treatment of cancer, today announced the creation of

2015-02-24 08:35:22

LAKE FOREST, Calif., Feb. 24, 2015 /PRNewswire/ -- Cryoport, Inc.

2015-02-24 08:34:14

Move puts company in ideal position to attract top scientific and medical talent to advance OncoVAX® clinical trial BALTIMORE, Feb.

2015-02-18 16:26:54

LOS ANGELES, Feb. 18, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced the appointment of Steven J.

2015-02-09 08:31:50

Selective RORgamma agonist product candidates demonstrated activity as single agent therapy NEW YORK and ANN ARBOR, Mich., Feb.

2015-01-28 08:31:47

Proceeds will Fund ACTIVE: the Phase IIIb OncoVAX® Trial and Company Expansion FREDERICK, Md., Jan.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related